HealthQuill Cancer
A hunting community, as far as Northeastern Greenland has some of the world’s highest concentrations of harmful polyfluoroalkyl substances (PFAS), a Danish study found.
Climate Drugs Pharma

Greenland’s hunting community reports high PFAS levels

HQ Team July 13, 2023: A hunting community, as far as Northeastern Greenland has some of the world’s highest concentrations of harmful polyfluoroalkyl.

Read More
Patients with cancer are markedly insulin-resistant, similar to people with type 2 diabetes, and it can lead to cancer spreading faster, according to a study by researchers at the University of Copenhagen.
Drugs Health Pharma

Cancer spreads faster when patient is insulin-resistant: Danish study

HQ Team June 21, 2023: Patients with cancer are markedly insulin-resistant, similar to people with type 2 diabetes, and it can lead to.

Read More
obesity
Climate Health Medical

An epidemic of early onset cancer hits the younger generation

HQ Team June 16, 2023: Cancer has been striking young people more in recent times. A recent study in Nature dubs it the early-onset cancer.

Read More
Tobacco companies put profit before public health, and the WHO has urged nations not to work or partner with these firms.
Drugs Health Medical

Don’t accept funds or work with the tobacco industry, WHO tells nations

HQ Team May 4, 2023: Tobacco companies put profit before public health, and the WHO has urged nations not to work or partner.

Read More
US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from eventual revenue loss as patents on its cancer immunotherapy Keytruda expires by the end of the decade.
Drugs Pharma

Merck to acquire Prometheus for $10.8 billion to step up immunology presence

HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from.

Read More
Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid tumors.
Drugs Health Pharma

Canada’s Fusion gets FDA nod for drug tests to treat solid tumors

HQ Team April 13, 2023: Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid.

Read More
U.S. Bankruptcy Court for the District of New Jersey
Drugs Health Medical Pharma

J&J raises talc settlement to $8.9 billion, unit files for a second bankruptcy

HQ Team April 5, 2023: Johnson and Johnson, a US multinational making pharmaceuticals and medical devices, has offered to pay $8.9 billion to.

Read More
BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer antibody drug candidates.
Drugs Medical Pharma

BioNTech, Duality Biologics sign $1.5 billion pact for cancer drugs

HQ Team April 3, 2023: BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer.

Read More
The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories, after Yemen and Lebanon raised concerns.
Drugs Medical Pharma

Yemen, Lebanon allege India’s Celon Labs’ drug ‘substandard’

The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories,.

Read More
BioNTech, a Germany-based biotechnology company, is expected to spend between 2.4 million euros and 2.6 million euros on research this year compared with 1.5 million euros last year.
Drugs Medical Pharma

BioNTech in one million euro push for research on drugs

BioNTech, a Germany-based biotechnology company, is expected to spend between 2.4 million euros and 2.6 million euros on research this year compared with.

Read More